1. Evaluation of the immunological cellular response of Cebus apella exposed to the carcinogen N-methyl-N-nitrosourea and treated with CANOVA®.
- Author
-
Feio DC, Muniz JA, Montenegro RC, Burbano RR, De Brito Junior LC, and De Lima PD
- Subjects
- Animals, Antigens, Surface metabolism, Carcinogens administration & dosage, Cebus, Cell Cycle drug effects, Crotalid Venoms administration & dosage, Immunophenotyping, Lymphocytes drug effects, Lymphocytes immunology, Lymphocytes metabolism, Methylnitrosourea administration & dosage, Plant Extracts administration & dosage, Carcinogens toxicity, Crotalid Venoms pharmacology, Immunity, Cellular drug effects, Immunity, Cellular immunology, Methylnitrosourea toxicity, Plant Extracts pharmacology
- Abstract
The immune response modifier Canova® is a homeopathic remedy indicated for patients with depressed immune system, since this drug appears to increase adaptive immunity and induce an immune response against multiple and severe pathological conditions, including cancer. We evaluated the pattern of immune cellular response in non-human primates of the species Cebus apella exposed to N-methyl-N-nitrosourea (MNU) with and without Canova®. Twelve animals were divided into four groups, with three animals each: negative control and three experimental groups, MNU-alone (35 days); MNU (35 days)-plus-Canova® (3 days) and Canova®-alone (3 days). The animals received MNU orally and Canova® by three intravenous injections. Evaluation of the cellular immune response was performed by immunophenotyping of T-lymphocytes (CD4(+), CD8(+)), B-lymphocytes and natural killer cells. Analysis was also performed of the cell cycle. Our results suggest an increase of T-lymphocytes (CD4(+)CD3(+)) only in the Canova® group, while in the MNU-plus-Canova® group only B-lymphocytes increased., (Copyright © 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.)
- Published
- 2014